Get software! [General Sta­tis­tics]

posted by verstc – China, 2018-06-17 14:55 (855 d 20:29 ago) – Posting: # 18910
Views: 4,196

Dear Helmut,

Thanks a lot for your reply.

It is clear to me for your explain.

I am wondering if there is a way to reduce the intra-subject CV. I think intra-subject CV is an inherent characteristic of a drug. is it right? If it not, does anyone can reduce it by any ways?

Thanks,

best,
Shawn


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

Activity
 Admin contact
21,165 posts in 4,411 threads, 1,474 registered users;
online 22 (2 registered, 20 guests [including 8 identified bots]).
Forum time: Tuesday 11:24 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5